Identity
- Security key
- 12117
- Ticker
- AVR
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-12-13
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- AVR
Detail
Enriched 2026-08-14 20:47
- Market cap
- $864,456,664.38
- Shares outstanding (class)
- 97,342,203
- Shares outstanding (weighted)
- 97,458,474
- SIC
- 3842 ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Employees
- 174
- Location
- EAGAN, MN
- Homepage
- https://www.anteristech.com
- Description
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.